Prot# CSTl571E2205: A Multi-Centre, Open-Label, Proof of Concept (PoC) Study to Evaluate the Efficacy and Tolerability of STl571 for the Treatment of Fibrosis in Patients with Systemic Sclerosis

Project: Research project

Project Details

StatusFinished
Effective start/end date12/10/072/28/10

Funding

  • Novartis Pharmaceuticals Corporation (CSTl571E2205)